RecruitingNCT04972136
rTMS for Depression in Young Adults With Autism
What is this study about?
In TorontoThis study evaluates the effectiveness of transcranial magnetic stimulation for people with depression.
DepressionDevice studyAges 16–35
Study directory
Back to overviewDepression studies
Depression involves persistent low mood or loss of interest, often with tiredness and changes in sleep or appetite.
RecruitingNCT05295888
Temporal Interference and Depression
Official study title
In TorontoEvaluation of Temporal Interference in Target Engagement of Subgenual Cingulate Cortex in the Treatment of Major Depressive Disorder
DepressionDevice studyAges 18–65
RecruitingNCT07188623
Virtual Reality-Enhanced Behavioral Activation for Older Adults With Depression
Official study title
In StanfordVR-Enhanced BA for Older Adults With Major Depressive Disorder
DepressionBehavioural studyAges 65+
Not Yet RecruitingNCT07566104
Group PACBT for Depression
Official study title
Group Psilocybin-assisted Cognitive Behavioral Therapy for Major Depressive Disorder
This study isn't recruiting yet.
In Los AngelesDepressionMedication studyAges 21–60
Not Yet RecruitingNCT07596914
Multi-site Feasibility of an Integrated Treatment for the Biology and Experience of Depression: The MULTIBED Study
Official study title
Assessing Multi-site Feasibility of an Integrated Whole-body Hyperthermia and Behavioral Intervention for Major Depressive Disorder: The MULTIBED Study
This study isn't recruiting yet.
Multiple locations, including San FranciscoDepressionDevice studyAges 18+
Not Yet RecruitingNCT07329153
Neuronavigated aiTBS for TRD
Official study title
Neuronavigated and Non-Neuronavigated Accelerated Intermittent Theta-Burst Stimulation for Treatment-Resistant Depression A Sham-Controlled Randomized Controlled Trial
This study isn't recruiting yet.
Multiple locations, including San DiegoDepressionDevice studyAges 18–65
Not Yet RecruitingNCT07480486
Pharmacogenetic-Guided Antidepressant Treatment in Depression
Official study title
Pharmacogenetic-Guided Antidepressant Treatment for Major Depressive Disorder: A Randomized Controlled Trial in Morocco
This study isn't recruiting yet.
In RabatDepressionStudy assessmentsAges 18+
Not Yet RecruitingNCT07052058
Triple-Blind study of Tocilizumab vs Placebo: Potential Use of an IL-6 Antagonist as an Adjuvant to Standard Treatment for Treatment-Resistant Major Depression in the Brazilian Public Health System (SUS)
Official study title
Triple-Blind Randomized Clinical Trial of Tocilizumab vs Placebo: Potential Use of an IL-6 Antagonist as an Adjuvant to Standard Treatment for Treatment-Resistant Major Depression in the Brazilian Public Health System (SUS)
This study isn't recruiting yet.
In Porto AlegreDepressionPlacebo comparisonAges 18–65
RecruitingNCT06668571
Intravenous Ketamine for Treatment-Resistant Depression
Official study title
In RochesterCentral and Peripheral GABA and Glutamate Modulation With Intravenous Ketamine for Treatment-Resistant Depression (G2K): A Randomized, Double-Blind, Placebo-Controlled Study
DepressionMedication studyAges 18–65
RecruitingNCT07673913
Relationship of Peripheral Inflammatory and Neuroprotective Biomarkers With Response to Intermittent Theta Burst Stimulation in Treatment-Resistant Depression
Official study title
In AnkaraRelationship Between Response to Transcranial Magnetic Stimulation and Peripheral Inflammatory and Neuroprotective Biomarkers in Patients With Treatment-Resistant Depression
DepressionDevice studyAges 18–55
Not Yet RecruitingNCT07529574
Theta Burst Stimulation Protocol of Repetitive Transcranial Magnetic Stimulation for treatment-resistant depression
What is this study about?
This study evaluates the safety and effectiveness of transcranial magnetic stimulation for people with depression.
This study isn't recruiting yet.
In SeoulDepressionMedication studyAges 15+
RecruitingNCT07621237
TNX-102 SL Monotherapy Versus Placebo in people with Major Depressive Disorder (MDD)
What is this study about?
Multiple locations, including PhoenixThis study evaluates the safety and effectiveness of TNX-102 SL for people with depression.
DepressionMedication studyAges 18+
Public registry coverage is progressing
HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.